Aquestive Therapeutics Inc Conference Call Transcript
Ladies and gentlemen, thank you for your standing by, and welcome to Aquestive Therapeutics conference call. (Operator Instructions)
I would now like to turn the conference over to your first presenter, Ms. Stephanie Carrington, Westwicke Investor Relations. Please go ahead, ma'am.
Thank you, operator. Good evening and welcome to today's conference call. On today's call, I am joined by Keith Kendall, Chief Executive Officer; Dan Barber, Chief Operating Officer; and John Maxwell, Chief Financial Officer, who are going to provide an overview of the recent business development. In addition, additional members of the Aquestive team will be available for Q&A. In total, we expect today's call to last approximately 60 minutes.
As a reminder, the company's remarks today correspond with the press release that we issued after market close today in a Form 8-K that was filed with the Securities and Exchange Commission, containing prepared responses to anticipated questions during this call and relevant charts to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |